Insights

Innovative AI Solutions MAbSilico specializes in AI-powered antibody drug discovery, offering rapid in silico candidate generation and validation, which positions them as a cutting-edge partner for biotech and pharma companies seeking to accelerate their development pipelines.

Recent Service Launch The company recently introduced an AI-driven HDX-MS epitope mapping service, demonstrating their commitment to expanding innovative offerings that can enhance antibody characterization and development efforts for clients.

Strategic Collaborations Partnership with Ose Immuno and other collaborations indicate strong industry validation and open doors for joint projects, providing opportunities to offer integrated solutions to leading biotech firms.

Market Expansion Expansion of offices in Europe and plans to hire additional staff across multiple disciplines suggest ongoing growth, making the company a promising partner for companies looking to leverage their regional presence and technical expertise.

Financial Opportunity Although currently with modest revenue, MAbSilico's focus on innovative technologies and recent service launches present significant upsell potential for advanced analytics, biological validation, and customized AI solutions to near-term clients in the biotech industry.

MAbSilico Tech Stack

MAbSilico uses 8 technology products and services including Cloudflare, Open Graph, Google Workspace, and more. Explore MAbSilico's tech stack below.

Cloudflare

Content Management System

Open Graph

Content Management System

Google Workspace

Lodash

Javascript Libraries

Google Maps

Maps

HubSpot

Marketing Automation

Google Tag Manager

Tag Management

HTTP/3

Web & Portal Technology

MAbSilico Email Formats	Example	Percentage
First.Last@mabsilico.com	John.Doe@mabsilico.com	100%

MAbSilico Email Formats

Example

Percentage

First.Last@mabsilico.com

John.Doe@mabsilico.com

100%

Frequently Asked Questions

Where is MAbSilico's headquarters located?

MAbSilico's main headquarters is located at Tours, Centre-val de Loire France. The company has employees across 2 continents, including EuropeAsia.

What is MAbSilico's official website and social media links?

MAbSilico's official website is mabsilico.com and has social profiles on LinkedIn.

What is MAbSilico's SIC code NAICS code?

MAbSilico's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MAbSilico have currently?

As of April 2026, MAbSilico has approximately 13 employees across 2 continents, including EuropeAsia. Key team members include Ceo And Co-Founder: V. P.Co-Founder: T. B.Cofounder & Head Of Biology: A. M.. Explore MAbSilico's employee directory with LeadIQ.

What industry does MAbSilico belong to?

MAbSilico operates in the Biotechnology Research industry.

What technology does MAbSilico use?

MAbSilico's tech stack includes CloudflareOpen GraphGoogle WorkspaceLodashGoogle MapsHubSpotGoogle Tag ManagerHTTP/3.

What is MAbSilico's email format?

MAbSilico's email format typically follows the pattern of First.Last@mabsilico.com. Find more MAbSilico email formats with LeadIQ.

When was MAbSilico founded?

MAbSilico was founded in 2017.

MAbSilico

Q: What is MAbSilico's official website and social media links?

MAbSilico's official website is mabsilico.com. MAbSilico has social profiles on LinkedIn.

Q: How many employees does MAbSilico have currently?

MAbSilico has approximately 13 employees.

Q: What technology does MAbSilico use?

MAbSilico's tech stack includes Cloudflare Bot Management, Webflow, Cloudflare, HTTP/3, Slick.

Q: What is MAbSilico's NAICS code?

MAbSilico's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchCentre-val de Loire, France11-50 Employees

MAbSilico is a TechBio company developing and providing AI-based solutions for antibody drug design and discovery. 

We help biotech and pharma companies to leverage antibody discovery risks by providing computational candidates in days which are designed and characterized in silico and validated with state-of-the-art biological technologies. 

While MAbSilico combines 3D modeling, interaction simulation and linear sequences analysis, the antibody drug candidates are defined through their epitope, affinity, off-target risk, cross-species reactivity and developability assessment to be ready for biological activity evaluation.

Using NLP technologies we gather information about antibodies and their target in different databases to ensure competitive landscape analysis and the freedom to operate of the computationally designed antibodies candidates.

Insights

Similar companies to MAbSilico

Rani Therapeutics

MAbSilico Tech Stack

Media & News

Ose Immuno partnered with MAbSilico on Jan 1st '20.

MAbSilico launched AI-driven HDX-MS epitope mapping service for antibody development on Mar 13th '24.

MAbSilico expands offices in Tours, France, Western Europe, Europe.

MAbSilico's Email Address Formats